tiprankstipranks
Trending News
More News >
Immunovant (IMVT)
NASDAQ:IMVT
US Market

Immunovant (IMVT) Cash flow

Compare
915 Followers

Immunovant Cash Flow

IMVT's free cash flow for Q2 2026 was $-102.52M. For the 2026 fiscal year, IMVT's free cash flow was decreased by $-162.05M and operating cash flow was $-102.52M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
$ -375.87M$ -214.23M$ -188.19M$ -106.11M$ -83.33M
Investing Cash Flow
$ -759.00K$ -360.00K$ -197.00K$ -254.00K$ -210.00K
Financing Cash Flow
$ 454.49M$ 472.43M$ 70.89M$ 200.13M$ 383.11M
End Cash Position
$ 713.97M$ 635.37M$ 376.53M$ 493.82M$ 400.15M
Free Cash Flow
$ -376.63M$ -214.59M$ -188.39M$ -106.37M$ -83.54M
Currency in USD

Immunovant Cash Flow